Skip to main content

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Tuesday, March 8, 2022 at 11:50am PT / 2:50pm ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  211.51
+2.95 (1.42%)
AAPL  273.31
+1.17 (0.43%)
AMD  212.44
-1.41 (-0.66%)
BAC  51.12
+0.71 (1.41%)
GOOG  312.07
+1.15 (0.37%)
META  651.34
+12.04 (1.88%)
MSFT  398.17
+9.17 (2.36%)
NVDA  196.26
+3.41 (1.77%)
ORCL  153.20
+7.06 (4.83%)
TSLA  415.43
+6.05 (1.48%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.